{"ABMD": {"Ticker": "ABMD", "Company": "Abiomed", "Sector": "Health Care", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$300"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Mizuho"], "Price_Target": 300.0}, "APD": {"Ticker": "APD", "Company": "Air Products & Chemicals", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "Seaport Research Partners", "Rating_Change": "Neutral to Buy", "Target_Change": "$300"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$295"}, {"Date": "2022-08-15", "Rating": "Upgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$283 to $321"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["BMO Capital Markets", "Goldman", "Seaport Research Partners"], "Price_Target": 305.33}, "ALB": {"Ticker": "ALB", "Company": "Albemarle Corporation", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Downgrade", "Organization": "Berenberg", "Rating_Change": "Buy to Hold", "Target_Change": "$260 to $270"}, {"Date": "2022-07-20", "Rating": "Upgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Underweight to Sector Weight", "Target_Change": ""}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["KeyBanc Capital Markets", "Berenberg"], "Price_Target": 270.0}, "AMCR": {"Ticker": "AMCR", "Company": "Amcor", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Buy", "Target_Change": ""}, {"Date": "2022-08-18", "Rating": "Downgrade", "Organization": "Macquarie", "Rating_Change": "Outperform to Neutral", "Target_Change": ""}, {"Date": "2022-08-18", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Underperform", "Target_Change": ""}, {"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": ""}, {"Date": "2022-07-19", "Rating": "Initiated", "Organization": "CLSA", "Rating_Change": "Buy", "Target_Change": ""}], "Score": 0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Morgan Stanley", "BofA Securities", "Macquarie", "CLSA"], "Price_Target": 0}, "AXP": {"Ticker": "AXP", "Company": "American Express", "Sector": "Financials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Sell", "Target_Change": "$159 to $130"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Citigroup"], "Price_Target": 130.0}, "AAPL": {"Ticker": "AAPL", "Company": "Apple", "Sector": "Information Technology", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$201 to $190"}, {"Date": "2022-10-11", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$169 to $155"}, {"Date": "2022-09-29", "Rating": "Upgrade", "Organization": "Rosenblatt", "Rating_Change": "Neutral to Buy", "Target_Change": "$160 to $189"}, {"Date": "2022-09-29", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$185 to $160"}, {"Date": "2022-08-17", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Outperform", "Target_Change": "$201"}, {"Date": "2022-07-26", "Rating": "Initiated", "Organization": "Itau BBA", "Rating_Change": "Underperform", "Target_Change": "$136"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$205 to $185"}, {"Date": "2022-07-20", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$185 to $180"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 8, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Rosenblatt", "Morgan Stanley", "BofA Securities", "Barclays", "Itau BBA", "Wells Fargo", "Credit Suisse"], "Price_Target": 174.5}, "AVY": {"Ticker": "AVY", "Company": "Avery Dennison", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$206 to $172"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities"], "Price_Target": 172.0}, "BIIB": {"Ticker": "BIIB", "Company": "Biogen", "Sector": "Health Care", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Hold to Buy", "Target_Change": "$223 to $299"}, {"Date": "2022-10-07", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": "$300"}, {"Date": "2022-09-28", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$224 to $340"}, {"Date": "2022-09-28", "Rating": "Upgrade", "Organization": "Mizuho", "Rating_Change": "Neutral to Buy", "Target_Change": "$207 to $270"}, {"Date": "2022-09-28", "Rating": "Upgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$217 to $360"}], "Score": 1.6, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Argus", "BMO Capital Markets", "Robert W. Baird", "Mizuho", "Stifel"], "Price_Target": 313.8}, "CL": {"Ticker": "CL", "Company": "Colgate-Palmolive", "Sector": "Consumer Staples", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$79"}, {"Date": "2022-08-01", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$71 to $80"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["JP Morgan", "Wells Fargo"], "Price_Target": 79.5}, "CMCSA": {"Ticker": "CMCSA", "Company": "Comcast", "Sector": "Communication Services", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$42 to $36"}, {"Date": "2022-08-15", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$60 to $44"}, {"Date": "2022-08-05", "Rating": "Downgrade", "Organization": "Redburn", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-08-01", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$48 to $42"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Underperform", "Target_Change": "$39"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Macquarie", "Rating_Change": "Neutral to Underperform", "Target_Change": "$40 to $33"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$52 to $45"}], "Score": -1.29, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 7, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Redburn", "JP Morgan", "Macquarie", "Citigroup", "Barclays", "Wolfe Research", "Atlantic Equities"], "Price_Target": 39.83}, "DOW": {"Ticker": "DOW", "Company": "Dow", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$50"}, {"Date": "2022-09-13", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$71 to $45"}, {"Date": "2022-09-02", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$60 to $47"}, {"Date": "2022-08-29", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Underweight", "Target_Change": "$45"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Jefferies", "Goldman", "JP Morgan", "KeyBanc Capital Markets"], "Price_Target": 46.75}, "EMN": {"Ticker": "EMN", "Company": "Eastman Chemical", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$78"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$116"}, {"Date": "2022-09-14", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$110 to $95"}, {"Date": "2022-08-01", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$102"}], "Score": -0.75, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Citigroup", "Mizuho", "Goldman", "Wells Fargo"], "Price_Target": 97.75}, "ECL": {"Ticker": "ECL", "Company": "Ecolab", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "Seaport Research Partners", "Rating_Change": "Neutral to Buy", "Target_Change": "$190"}, {"Date": "2022-09-06", "Rating": "Upgrade", "Organization": "Northcoast", "Rating_Change": "Neutral to Buy", "Target_Change": "$188"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Northcoast", "Seaport Research Partners"], "Price_Target": 189.0}, "HOLX": {"Ticker": "HOLX", "Company": "Hologic", "Sector": "Health Care", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$75"}, {"Date": "2022-07-20", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$73"}, {"Date": "2022-07-20", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$81 to $75"}, {"Date": "2022-07-18", "Rating": "Downgrade", "Organization": "BTIG Research", "Rating_Change": "Buy to Neutral", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "Mizuho", "BofA Securities", "BTIG Research"], "Price_Target": 74.33}, "ISRG": {"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$215"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$210"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Mizuho"], "Price_Target": 212.5}, "LVS": {"Ticker": "LVS", "Company": "Las Vegas Sands", "Sector": "Consumer Discretionary", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": "$37"}, {"Date": "2022-09-26", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-07-21", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$43 to $45"}], "Score": 1.33, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "BofA Securities", "Wells Fargo"], "Price_Target": 41.0}, "LIN": {"Ticker": "LIN", "Company": "Linde", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "Seaport Research Partners", "Rating_Change": "Neutral to Buy", "Target_Change": "$330"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$338"}, {"Date": "2022-08-10", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Hold to Buy", "Target_Change": ""}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Stifel", "Goldman", "Seaport Research Partners"], "Price_Target": 334.0}, "LYB": {"Ticker": "LYB", "Company": "LyondellBasell", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Sell", "Target_Change": "$80"}, {"Date": "2022-09-02", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$115 to $80"}, {"Date": "2022-08-29", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Underweight", "Target_Change": "$73"}, {"Date": "2022-08-01", "Rating": "Downgrade", "Organization": "Vertical Research", "Rating_Change": "Buy to Hold", "Target_Change": "$96"}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["JP Morgan", "Vertical Research", "Goldman", "KeyBanc Capital Markets"], "Price_Target": 82.25}, "MA": {"Ticker": "MA", "Company": "Mastercard", "Sector": "Information Technology", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$440 to $375"}, {"Date": "2022-08-16", "Rating": "Downgrade", "Organization": "Daiwa Securities", "Rating_Change": "Outperform to Neutral", "Target_Change": "$385 to $375"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Deutsche Bank", "Daiwa Securities"], "Price_Target": 375.0}, "MDT": {"Ticker": "MDT", "Company": "Medtronic", "Sector": "Health Care", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$100"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$87"}, {"Date": "2022-08-24", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Mizuho", "Raymond James"], "Price_Target": 93.5}, "NKE": {"Ticker": "NKE", "Company": "Nike", "Sector": "Consumer Discretionary", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$99"}, {"Date": "2022-10-03", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$156 to $141"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$125 to $110"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$130 to $110"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$125 to $115"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$115 to $95"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$129 to $120"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$130 to $120"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$130 to $115"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Guggenheim", "Rating_Change": "Buy", "Target_Change": "$155 to $135"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$123 to $99"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$124 to $110"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$127 to $114"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$113 to $93"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$122 to $100"}, {"Date": "2022-09-26", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$130 to $125"}, {"Date": "2022-09-22", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$125"}, {"Date": "2022-09-20", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$125 to $110"}, {"Date": "2022-08-09", "Rating": "Downgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform to Neutral", "Target_Change": "$118"}, {"Date": "2022-07-26", "Rating": "Resumed", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$115"}, {"Date": "2022-07-21", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight", "Target_Change": ""}], "Score": 1.05, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 22, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Exane BNP Paribas", "Telsey Advisory Group", "Deutsche Bank", "RBC Capital Mkts", "Piper Sandler", "Credit Suisse", "Jefferies", "Argus", "UBS", "Morgan Stanley", "KeyBanc Capital Markets", "Citigroup", "Barclays", "Stifel", "Cowen", "Guggenheim", "JP Morgan", "BofA Securities", "Raymond James"], "Price_Target": 113.45}, "PPG": {"Ticker": "PPG", "Company": "PPG Industries", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$145"}, {"Date": "2022-09-06", "Rating": "Upgrade", "Organization": "Redburn", "Rating_Change": "Neutral to Buy", "Target_Change": ""}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Redburn", "Goldman"], "Price_Target": 145.0}, "PLD": {"Ticker": "PLD", "Company": "Prologis", "Sector": "Real Estate", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$128"}, {"Date": "2022-10-04", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$120"}, {"Date": "2022-09-27", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$133 to $127"}, {"Date": "2022-08-24", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": ""}], "Score": 1.75, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Wolfe Research", "Evercore ISI", "Stifel", "Citigroup"], "Price_Target": 125.0}, "O": {"Ticker": "O", "Company": "Realty Income Corporation", "Sector": "Real Estate", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$61"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Mizuho"], "Price_Target": 61.0}, "SHW": {"Ticker": "SHW", "Company": "Sherwin-Williams", "Sector": "Materials", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "Seaport Research Partners", "Rating_Change": "Neutral to Buy", "Target_Change": "$275"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$280"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Goldman", "Seaport Research Partners"], "Price_Target": 277.5}, "UAA": {"Ticker": "UAA", "Company": "Under Armour (Class A)", "Sector": "Consumer Discretionary", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Mkt Perform", "Target_Change": ""}, {"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$12 to $10"}, {"Date": "2022-07-26", "Rating": "Resumed", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$10"}], "Score": -0.67, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Raymond James", "Robert W. Baird", "Piper Sandler"], "Price_Target": 10.0}, "V": {"Ticker": "V", "Company": "Visa", "Sector": "Information Technology", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$270 to $260"}, {"Date": "2022-08-16", "Rating": "Downgrade", "Organization": "Daiwa Securities", "Rating_Change": "Outperform to Neutral", "Target_Change": "$230 to $225"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Deutsche Bank", "Daiwa Securities"], "Price_Target": 242.5}}